NCT02071329View on ClinicalTrials.gov

Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Influenza A
Interventions
DRUG

Vaccine FP-01.1

DRUG

Placebo

OTHER

Virus Challenge

Trial Locations (1)

Unknown

Quintiles Drug Research Unit at Guy's Hospital, London

Sponsors
All Listed Sponsors
lead

Immune Targeting Systems Ltd

INDUSTRY